AU2002216968A1 - Plasma fraction containing bikunin, method for the production thereof and use of the same - Google Patents

Plasma fraction containing bikunin, method for the production thereof and use of the same

Info

Publication number
AU2002216968A1
AU2002216968A1 AU2002216968A AU1696802A AU2002216968A1 AU 2002216968 A1 AU2002216968 A1 AU 2002216968A1 AU 2002216968 A AU2002216968 A AU 2002216968A AU 1696802 A AU1696802 A AU 1696802A AU 2002216968 A1 AU2002216968 A1 AU 2002216968A1
Authority
AU
Australia
Prior art keywords
bikunin
production
same
fraction containing
plasma fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002216968A
Other languages
English (en)
Inventor
Djuro Josic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Octapharma AG
Original Assignee
Octapharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma AG filed Critical Octapharma AG
Publication of AU2002216968A1 publication Critical patent/AU2002216968A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002216968A 2000-10-13 2001-10-11 Plasma fraction containing bikunin, method for the production thereof and use of the same Abandoned AU2002216968A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10050665.8 2000-10-13
DE10050665 2000-10-13
PCT/EP2001/011994 WO2002030983A2 (de) 2000-10-13 2001-10-11 Bikunin enthaltende plasmafraktion, verfahren zu ihrer herstellung und ihrer verwendung

Publications (1)

Publication Number Publication Date
AU2002216968A1 true AU2002216968A1 (en) 2002-04-22

Family

ID=7659599

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002216968A Abandoned AU2002216968A1 (en) 2000-10-13 2001-10-11 Plasma fraction containing bikunin, method for the production thereof and use of the same

Country Status (5)

Country Link
US (1) US20030190732A1 (de)
EP (1) EP1326893A2 (de)
JP (1) JP2004511492A (de)
AU (1) AU2002216968A1 (de)
WO (1) WO2002030983A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007536206A (ja) * 2003-10-16 2007-12-13 バイエル・ヘルスケア・エルエルシー 尿中トリプシンインヒビターを検出するためのモノクローナル抗体
CA2544816A1 (en) * 2003-11-08 2005-05-26 Prothera Biologics, Llc Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
CN103142650B (zh) * 2004-11-05 2016-05-11 普罗瑟拉生物公司 治疗用途的来自人血浆的内-α抑制剂蛋白质的制备和组合物
CN101160133B (zh) * 2004-11-05 2013-01-09 普罗瑟拉生物公司 治疗用途的来自人血浆的内-α抑制剂蛋白质的制备和组合物
FR2894145B1 (fr) * 2005-12-07 2008-10-17 Lab Francais Du Fractionnement Utilisation de facteur h du complement a titre de medicament
BRPI0913949A2 (pt) 2008-05-28 2015-10-20 Pro Thera Biolog Llc preparação e composição de proteínas inibidoras inter-alfa a partir de sangue
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
US8841248B2 (en) 2010-07-23 2014-09-23 Baxter International Inc. Manufacture of inter-alpha-inhibitor (IaIp) from plasma
WO2014039987A2 (en) 2012-09-09 2014-03-13 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
US20140206844A1 (en) 2013-01-18 2014-07-24 Prothera Biologics Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material
AU2021377336A1 (en) 2020-11-16 2023-07-06 Prothera Biologics, Inc. Methods for purifying inter-alpha inhibitor proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846763A (en) * 1991-01-14 1998-12-08 New York University DNA encoding tumor necrosis factor stimulated gene 6 (TSG-6)
FR2711371B1 (fr) * 1993-10-18 1995-12-29 Aetsrn Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu.

Also Published As

Publication number Publication date
WO2002030983A3 (de) 2002-12-12
EP1326893A2 (de) 2003-07-16
US20030190732A1 (en) 2003-10-09
JP2004511492A (ja) 2004-04-15
WO2002030983A2 (de) 2002-04-18

Similar Documents

Publication Publication Date Title
AU2002224927A1 (en) Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
AU4467801A (en) Chlamydospores and process for producing the same
AU2002232819A1 (en) Methods for the production of multimeric proteins, and related compositions
AU2002216968A1 (en) Plasma fraction containing bikunin, method for the production thereof and use of the same
AU2001230207A1 (en) Method for the production of 1-amino-3-aryl-uracils
AU2001279537A1 (en) Method and arrangement for the production of crossed stacks
AU2000267917A1 (en) Gas separation process
AU2001262229A1 (en) Cyclipostins, a method for their production and the use of the same
AU2002365372A1 (en) New process
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
AU2002348998A1 (en) N-methyl-homocystines, use thereof and method for the production thereof
AU2001274004A1 (en) Method for the production of 2- coumarone and substituted 2-coumarones
AU2002227952A1 (en) Klainetin and derivatives thereof, method for their production and the use of the same
AU2002352606A1 (en) Eurotinone and derivatives thereof, method for the production and use of the same
AU6730001A (en) Component, method for production and use thereof
AU2001253386A1 (en) Haplotypes of the impdh2 gene
AU5462901A (en) Process for the preparation of (pyridinylidene)-phthalides
AU2002359931A1 (en) Compositions containing pigmentatin inhibitor, use thereof and process for producing the same
AU2001294181A1 (en) Novel protein, process for producing the same and use thereof
AU2001296510A1 (en) Haplotypes of the admr gene
AU2001263756A2 (en) Method for the distribution of articles
WO2001077913A8 (de) Verfahren zum verteilen von artikeln
AU2001263756A1 (en) Method for the distribution of articles
AU2002231651A1 (en) Process for the preparation of morpholinones
AU2002314155A1 (en) Curable mixtures of substances, method for the production and use thereof